EU Pharmaceutical Law Reform: A Chance to Meet Human Rights Standards

dc.contributor.authorOcana Noriega, Gema
dc.date.accessioned2024-01-18T17:24:02Z
dc.date.issued2024-01-18
dc.description.abstractThe European Commission has announced the largest reform of EU pharmaceutical legislation in over 20 years. It is worth exploring key elements of the proposals in light of the international human right to health and the duty to international assistance and cooperation
dc.description.sponsorshipEuropean Commission - Operating grant - Neighbourhood, Development and International Cooperation Instrument - Global Europe Instrument (NDICI)
dc.identifier.urihttps://repository.gchumanrights.org/handle/20.500.11825/3145
dc.identifier.urihttps://doi.org/10.25330/3054
dc.language.isoen
dc.publisherGlobal Campus of Human Rights
dc.relation.ispartofseriesRegional Correspondant Scheme n 3
dc.subjectright to health
dc.subjectpharmaceutical industry
dc.subjectmedical law and legislation
dc.subjectmedical care
dc.subjectinternational cooperation
dc.subjectEurope
dc.titleEU Pharmaceutical Law Reform: A Chance to Meet Human Rights Standards
dc.typeOther

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2023.01.18_Ocana Noriega_pharmaceutical industry_medical care_EU.pdf
Size:
171.66 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
18.68 KB
Format:
Item-specific license agreed upon to submission
Description: